We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current INVA market cap is 1.07B. The company's latest EPS is USD 4.3114 and P/E is 4.09.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 85.84M | 77.5M | 99.9M | 89.51M | 91.81M |
| Operating Income | 37.53M | 25.81M | 54.69M | 240k | 43.14M |
| Net Income | 61.53M | 36.53M | -34.69M | 1.21M | 267.16M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 336.79M | 391.87M | 331.34M | 310.46M | 358.71M |
| Operating Income | 321.12M | 375.1M | 207M | 113.89M | 166.87M |
| Net Income | 224.4M | 265.85M | 213.92M | 179.72M | 270.22M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.24B | 1.27B | 1.22B | 1.23B | 1.3B |
| Total Liabilities | 568.55M | 563.93M | 559.4M | 563.07M | 609.9M |
| Total Equity | 674.96M | 703.68M | 665.52M | 668.54M | 691.16M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 999.57M | 926.4M | 1.23B | 1.24B | 1.3B |
| Total Liabilities | 391.73M | 400.46M | 665.71M | 568.55M | 609.9M |
| Total Equity | 607.84M | 525.94M | 565.79M | 674.96M | 691.16M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 141.06M | 37.05M | 80.77M | 129.45M | 188.69M |
| Investing | -66.76M | -43.04M | -43.04M | -48.31M | -63.79M |
| Financing | -171.84M | -9.17M | -14.24M | -14.03M | -13.45M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 313.11M | 363.81M | 201.73M | 141.06M | 188.69M |
| Investing | -314.94M | 43.72M | -56.63M | -66.76M | -63.79M |
| Financing | -29.79M | -452.5M | -55.57M | -171.84M | -13.45M |
| Market Cap | 1.07B |
| Price to Earnings Ratio | 4.09 |
| Price to Sales Ratio | 3.08 |
| Price to Cash Ratio | 3.62 |
| Price to Book Ratio | 1.6 |
| Dividend Yield | - |
| Shares Outstanding | 62.68M |
| Average Volume (1 week) | 1.35M |
| Average Volume (1 Month) | 752.93k |
| 52 Week Change | 15.41% |
| 52 Week High | 21.28 |
| 52 Week Low | 14.325 |
| Spread (Intraday) | 2.25 (11.69%) |
| Company Name | Innoviva Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
